semaglutide nasal spray SPRAY: A NEWS? OR A FAKE NEWS? The China Center for Drug Evaluation (CDE) announced that Shiling Pharma's semaglutide nasal has been approved for clinical trials for… The first and only oral
Description
A complete, step-by-step program guide available as a downloadable ebook
Discover how to support your patients weight loss journeys with treatments that tackle skin laxity, increase satisfaction, and drive practice profitability
Oprah Winfrey has revealed that the GLP-1 weight loss medication she began taking in 2023 has unexpectedly curbed her desire to drink alcohol.
Retatrutide is still investigational, so its full safety profile is not yet established
Both drugs affect appetite and metabolism through different pathways, creating potential safety concerns and interaction risks that should be addressed with a qualified healthcare provider
